These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 18286571)

  • 1. IRAK4 in TLR/IL-1R signaling: possible clinical applications.
    Li X
    Eur J Immunol; 2008 Mar; 38(3):614-8. PubMed ID: 18286571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A critical role for IRAK4 kinase activity in Toll-like receptor-mediated innate immunity.
    Kim TW; Staschke K; Bulek K; Yao J; Peters K; Oh KH; Vandenburg Y; Xiao H; Qian W; Hamilton T; Min B; Sen G; Gilmour R; Li X
    J Exp Med; 2007 May; 204(5):1025-36. PubMed ID: 17470642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of IRAK4 and IRF3 in the control of intracellular infection with Chlamydia pneumoniae.
    Trumstedt C; Eriksson E; Lundberg AM; Yang TB; Yan ZQ; Wigzell H; Rottenberg ME
    J Leukoc Biol; 2007 Jun; 81(6):1591-8. PubMed ID: 17360955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pivotal Advance: Inhibition of MyD88 dimerization and recruitment of IRAK1 and IRAK4 by a novel peptidomimetic compound.
    Loiarro M; Capolunghi F; Fantò N; Gallo G; Campo S; Arseni B; Carsetti R; Carminati P; De Santis R; Ruggiero V; Sette C
    J Leukoc Biol; 2007 Oct; 82(4):801-10. PubMed ID: 17548806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The kinase activities of interleukin-1 receptor associated kinase (IRAK)-1 and 4 are redundant in the control of inflammatory cytokine expression in human cells.
    Song KW; Talamas FX; Suttmann RT; Olson PS; Barnett JW; Lee SW; Thompson KD; Jin S; Hekmat-Nejad M; Cai TZ; Manning AM; Hill RJ; Wong BR
    Mol Immunol; 2009 Apr; 46(7):1458-66. PubMed ID: 19181383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4.
    Suzuki N; Suzuki S; Duncan GS; Millar DG; Wada T; Mirtsos C; Takada H; Wakeham A; Itie A; Li S; Penninger JM; Wesche H; Ohashi PS; Mak TW; Yeh WC
    Nature; 2002 Apr; 416(6882):750-6. PubMed ID: 11923871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential regulation of interleukin 1 receptor and Toll-like receptor signaling by MEKK3.
    Huang Q; Yang J; Lin Y; Walker C; Cheng J; Liu ZG; Su B
    Nat Immunol; 2004 Jan; 5(1):98-103. PubMed ID: 14661019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PKC-alpha controls MYD88-dependent TLR/IL-1R signaling and cytokine production in mouse and human dendritic cells.
    Langlet C; Springael C; Johnson J; Thomas S; Flamand V; Leitges M; Goldman M; Aksoy E; Willems F
    Eur J Immunol; 2010 Feb; 40(2):505-15. PubMed ID: 19950169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin 1/Toll-like receptor-induced autophosphorylation activates interleukin 1 receptor-associated kinase 4 and controls cytokine induction in a cell type-specific manner.
    Cushing L; Stochaj W; Siegel M; Czerwinski R; Dower K; Wright Q; Hirschfield M; Casanova JL; Picard C; Puel A; Lin LL; Rao VR
    J Biol Chem; 2014 Apr; 289(15):10865-10875. PubMed ID: 24567333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential control of Toll-like receptor-dependent responses by IRAK1 and IRAK2.
    Kawagoe T; Sato S; Matsushita K; Kato H; Matsui K; Kumagai Y; Saitoh T; Kawai T; Takeuchi O; Akira S
    Nat Immunol; 2008 Jun; 9(6):684-91. PubMed ID: 18438411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solving the IRAK-4 enigma: application of kinase-dead knock-in mice.
    Koziczak-Holbro M; Joyce C; Glück A; Kinzel B; Müller M; Gram H
    Ernst Schering Found Symp Proc; 2007; (3):63-82. PubMed ID: 18510099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IRAK4 as a molecular target in the amelioration of innate immunity-related endotoxic shock and acute liver injury by chlorogenic acid.
    Park SH; Baek SI; Yun J; Lee S; Yoon DY; Jung JK; Jung SH; Hwang BY; Hong JT; Han SB; Kim Y
    J Immunol; 2015 Feb; 194(3):1122-30. PubMed ID: 25548221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interleukin-1 receptor-associated kinases: critical regulators of innate immune signalling.
    Flannery S; Bowie AG
    Biochem Pharmacol; 2010 Dec; 80(12):1981-91. PubMed ID: 20599782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and optimization of indolo[2,3-c]quinoline inhibitors of IRAK4.
    Tumey LN; Boschelli DH; Bhagirath N; Shim J; Murphy EA; Goodwin D; Bennett EM; Wang M; Lin LL; Press B; Shen M; Frisbie RK; Morgan P; Mohan S; Shin J; Rao VR
    Bioorg Med Chem Lett; 2014 May; 24(9):2066-72. PubMed ID: 24726805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of dysfunction of human variants of the IRAK4 kinase and a role for its kinase activity in interleukin-1 receptor signaling.
    De S; Karim F; Kiessu E; Cushing L; Lin LL; Ghandil P; Hoarau C; Casanova JL; Puel A; Rao VR
    J Biol Chem; 2018 Sep; 293(39):15208-15220. PubMed ID: 30115681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-1 receptor-associated kinase 4 (IRAK4) plays a dual role in myddosome formation and Toll-like receptor signaling.
    De Nardo D; Balka KR; Cardona Gloria Y; Rao VR; Latz E; Masters SL
    J Biol Chem; 2018 Sep; 293(39):15195-15207. PubMed ID: 30076215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of Toll-like receptor-induced chemokine production in murine dendritic cells by mitogen-activated protein kinases.
    Mitchell D; Olive C
    Mol Immunol; 2010 Jul; 47(11-12):2065-73. PubMed ID: 20451253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IRAK4 kinase activity is not required for induction of endotoxin tolerance but contributes to TLR2-mediated tolerance.
    Xiong Y; Pennini M; Vogel SN; Medvedev AE
    J Leukoc Biol; 2013 Aug; 94(2):291-300. PubMed ID: 23695305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic ablation of IRAK4 kinase activity inhibits vascular lesion formation.
    Rekhter M; Staschke K; Estridge T; Rutherford P; Jackson N; Gifford-Moore D; Foxworthy P; Reidy C; Huang XD; Kalbfleisch M; Hui K; Kuo MS; Gilmour R; Vlahos CJ
    Biochem Biophys Res Commun; 2008 Mar; 367(3):642-8. PubMed ID: 18190779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptors and chondrocytes: the lipopolysaccharide-induced decrease in cartilage matrix synthesis is dependent on the presence of toll-like receptor 4 and antagonized by bone morphogenetic protein 7.
    Bobacz K; Sunk IG; Hofstaetter JG; Amoyo L; Toma CD; Akira S; Weichhart T; Saemann M; Smolen JS
    Arthritis Rheum; 2007 Jun; 56(6):1880-93. PubMed ID: 17530716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.